Brege Laura — SEC Form 4 filings

SEC reporting owner CIK 1365619. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-05-31 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mirum Pharmaceuticals, Inc. (MIRM)Director42 legs · 17,000 sh · $1,264,86810
ACADIA PHARMACEUTICALS INC (ACAD)Director41 leg · 14,446 sh · $314,63412
Pacira BioSciences, Inc. (PCRX)Director41 leg · 1,000 sh · $12,8106
Edgewise Therapeutics, Inc. (EWTX)Director33

Form 4 filings — Brege Laura

FiledFormIssuerReported transactionsSource
2026-06-174Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 16,377 (derivative) @ $0EDGAR
2026-06-174Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 3,772 (derivative) @ $0 · Grant/award (A): 1,980 (derivative) @ $0EDGAR
2026-06-124Pacira BioSciences, Inc. (PCRX)Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-06-014ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 8,107 · Option exercise (M): 8,107 (derivative) @ $0 · Grant/award (A): 16,004 (derivative) @ $0 · Grant/award (A): 9,311 (derivative) @ $0EDGAR
2025-09-124Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 17,000 @ $15 · Sale (S): 15,509 @ $74.34 · Sale (S): 1,491 @ $75.07 · Option exercise (M): 17,000 (derivative) @ $0EDGAR
2025-06-184Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0EDGAR
2025-06-054ACADIA PHARMACEUTICALS INC (ACAD)Sale (S): 14,446 @ $21.78EDGAR
2025-06-024ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 9,387 · Option exercise (M): 9,387 (derivative) @ $0 · Grant/award (A): 13,793 (derivative) @ $0 · Grant/award (A): 8,107 (derivative) @ $0EDGAR
2025-06-024Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 5,703 · Option exercise (M): 5,703 (derivative) @ $0 · Grant/award (A): 6,268 (derivative) @ $0 · Grant/award (A): 3,977 (derivative) @ $0EDGAR
2024-08-194Pacira BioSciences, Inc. (PCRX)Purchase (P): 1,000 @ $12.81EDGAR
2024-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0EDGAR
2024-06-124Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 20,594 (derivative) @ $0EDGAR
2024-06-074Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 8,779 (derivative) @ $0 · Grant/award (A): 5,703 (derivative) @ $0EDGAR
2024-05-314ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 6,652 · Option exercise (M): 6,652 (derivative) @ $0 · Grant/award (A): 15,959 (derivative) @ $0 · Grant/award (A): 9,387 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1365619 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →